Spots Global Cancer Trial Database for Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen
Official Title: A Randomized, Open Label Multi-Center Study Of Single Agent Larotaxel (XRP9881) Compared To Continuous Administration of 5-FU For The Treatment Of Patients With Advanced Pancreatic Cancer Previously Treated With A Gemcitabine-Containing Regimen
Study ID: NCT00417209
Conditions
Study Description
Brief Summary: The purpose of this study is to compare the efficacy and the safety Larotaxel administered as single agent every 3 weeks to continuous administration of 5-FU every 3 weeks, in patients with advanced pancreatic cancer (non operable in a curative intent, locally recurrent or metastatic) previously treated with gemcitabine based therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Sanofi-Aventis Administrative Office, Diegem, , Belgium
Sanofi-Aventis Administrative Office, Sao Paulo, , Brazil
Sanofi-Aventis Administrative Office, Laval, Quebec, , Canada
Sanofi-Aventis Administrative Office, Santiago de Chile, , Chile
Sanofi-Aventis Administrative Office, Santafe de Bogota, , Colombia
Sanofi-Aventis Administrative Office, Praha, , Czech Republic
Sanofi-Aventis Administrative Office, Helsinki, , Finland
Sanofi-Aventis Administrative Office, Berlin, , Germany
Sanofi-Aventis Administrative Office, Budapest, , Hungary
Sanofi-Aventis Administrative Office, Mumbai, , India
Sanofi-Aventis Administrative Office, Milan, , Italy
Sanofi-Aventis Administrative Office, Mexico, , Mexico
Sanofi-Aventis Administrative Office, Lysaker, , Norway
Sanofi-Aventis Administrative Office, Lima, , Peru
Sanofi-Aventis Administrative Office, Warszawa, , Poland
Sanofi-Aventis Administrative Office, Moscow, , Russian Federation
Sanofi-Aventis Administrative Office, Brastislava, , Slovakia
Sanofi-Aventis Administrative Office, Madrid, , Spain
Sanofi-Aventis Administrative Office, Istanbul, , Turkey
Sanofi-Aventis Administrative Office, Guildford, Surrey, , United Kingdom
Contact Details
Name: ICD
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
